BackAlar Pharmaceuticals Overview

Alar Pharmaceuticals Long Term Debt

Track Alar Pharmaceuticals's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00
↓ 100.00% YoYΔ $-828000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Alar Pharmaceuticals Long Term Debt History

Loading

Alar Pharmaceuticals vs. peers: Long Term Debt Comparison

Loading

Alar Pharmaceuticals Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Alar Pharmaceuticals (6785.TWO) FAQ

Alar Pharmaceuticals (6785.TWO) currently reports a long-term debt of $0 as of June 2026. That compares with $830K in the prior-year period — down 100.0% year over year. Use the charts on this page to explore Alar Pharmaceuticals's long-term debt history and peer comparisons.

Alar Pharmaceuticals's long-term debt decreased from $830K to $0 — a 100.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alar Pharmaceuticals reported $0 in long-term debt as of June 2026. That compares with $830K in the prior-year period — down 100.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Alar Pharmaceuticals, and consider following 6785.TWO for alerts when major investors trade the stock.